ACUTAASPharmaceuticals
ACUTAAS CHEMICALS LIMITED — Profit & Loss Statement
₹2558.60
+0.70%
ACUTAAS CHEMICALS LIMITED Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | -9.63 Cr | -0.19 Cr | 0.00 | — |
| Tax Rate For Calcs | 0.26 | 0.30 | 0.26 | 0.21 | — |
| Normalized EBITDA | 249.00 Cr | 135.98 Cr | 127.67 Cr | 107.94 Cr | — |
| Total Unusual Items | 0.00 | -32.08 Cr | -0.75 Cr | 0.00 | — |
| Total Unusual Items Excluding Goodwill | 0.00 | -32.08 Cr | -0.75 Cr | 0.00 | — |
| Net Income From Continuing Operation Net Minority Interest | 160.42 Cr | 48.71 Cr | 83.29 Cr | 71.95 Cr | — |
| Reconciled Depreciation | 26.62 Cr | 16.06 Cr | 12.34 Cr | 10.08 Cr | — |
| Reconciled Cost Of Revenue | 552.18 Cr | 411.69 Cr | 373.68 Cr | 272.84 Cr | — |
| EBITDA | 249.00 Cr | 103.90 Cr | 126.93 Cr | 107.94 Cr | — |
| EBIT | 222.38 Cr | 87.84 Cr | 114.58 Cr | 97.86 Cr | — |
| Net Interest Income | -6.22 Cr | -5.94 Cr | -0.23 Cr | -6.41 Cr | — |
| Interest Expense | 6.22 Cr | 5.94 Cr | 2.41 Cr | 6.41 Cr | — |
| Normalized Income | 160.42 Cr | 71.17 Cr | 83.84 Cr | 71.95 Cr | — |
| Net Income From Continuing And Discontinued Operation | 160.42 Cr | 48.71 Cr | 83.29 Cr | 71.95 Cr | — |
| Total Expenses | 801.42 Cr | 605.04 Cr | 502.05 Cr | 425.04 Cr | — |
| Diluted Average Shares | 8.19 Cr | 7.38 Cr | 7.29 Cr | 6.84 Cr | — |
| Basic Average Shares | 8.19 Cr | 7.38 Cr | 7.29 Cr | 6.84 Cr | — |
| Diluted EPS | 9.90 | 2.92 | 11.43 | 10.52 | — |
| Basic EPS | 9.90 | 2.92 | 11.43 | 10.52 | — |
| Diluted NI Availto Com Stockholders | 160.42 Cr | 48.71 Cr | 83.29 Cr | 71.95 Cr | — |
| Net Income Common Stockholders | 160.42 Cr | 48.71 Cr | 83.29 Cr | 71.95 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 160.42 Cr | 48.71 Cr | 83.29 Cr | 71.95 Cr | — |
| Net Income Including Noncontrolling Interests | 160.42 Cr | 48.71 Cr | 83.29 Cr | 71.95 Cr | — |
| Net Income Continuous Operations | 160.42 Cr | 48.71 Cr | 83.29 Cr | 71.95 Cr | — |
| Tax Provision | 55.75 Cr | 33.19 Cr | 28.88 Cr | 19.50 Cr | — |
| Pretax Income | 216.16 Cr | 81.90 Cr | 112.17 Cr | 91.45 Cr | — |
| Other Non Operating Income Expenses | 16.93 Cr | 7.49 Cr | 86000.00 | 2.76 Cr | — |
| Special Income Charges | 0.00 | -32.08 Cr | -0.75 Cr | 0.00 | — |
| Net Non Operating Interest Income Expense | -6.22 Cr | -5.94 Cr | -0.23 Cr | -6.41 Cr | — |
| Interest Expense Non Operating | 6.22 Cr | 5.94 Cr | 2.41 Cr | 6.41 Cr | — |
| Operating Income | 205.45 Cr | 112.43 Cr | 111.01 Cr | 95.10 Cr | — |
| Operating Expense | 249.24 Cr | 193.35 Cr | 128.37 Cr | 152.20 Cr | — |
| Other Operating Expenses | 138.96 Cr | 114.18 Cr | 45.01 Cr | 100.76 Cr | — |
| Depreciation And Amortization In Income Statement | 26.62 Cr | 16.06 Cr | 12.34 Cr | 10.08 Cr | — |
| Depreciation Income Statement | 26.62 Cr | 16.06 Cr | 12.34 Cr | 10.08 Cr | — |
| Gross Profit | 454.69 Cr | 305.79 Cr | 239.38 Cr | 247.30 Cr | — |
| Cost Of Revenue | 552.18 Cr | 411.69 Cr | 373.68 Cr | 272.84 Cr | — |
| Total Revenue | 1.01K Cr | 717.47 Cr | 613.06 Cr | 520.13 Cr | — |
| Operating Revenue | 1.01K Cr | 717.47 Cr | 613.06 Cr | 520.13 Cr | — |
| Interest Income | — | 2.13 Cr | 2.18 Cr | 2.58 Cr | 0.20 Cr |
| Rent Expense Supplemental | — | 0.28 Cr | 0.38 Cr | 0.37 Cr | 0.30 Cr |
| Other Special Charges | — | 31.88 Cr | 0.75 Cr | — | 0.14 Cr |
| Interest Income Non Operating | — | 2.13 Cr | 2.18 Cr | 2.58 Cr | 0.20 Cr |
| Research And Development | — | 0.00 | 0.27 Cr | 0.12 Cr | 0.67 Cr |
| Selling General And Administration | — | 21.86 Cr | 24.61 Cr | 24.63 Cr | 9.13 Cr |
| Selling And Marketing Expense | — | 14.67 Cr | 18.80 Cr | 20.26 Cr | 7.01 Cr |
| General And Administrative Expense | — | 7.18 Cr | 5.81 Cr | 4.38 Cr | 2.12 Cr |
| Rent And Landing Fees | — | 0.28 Cr | 0.38 Cr | 0.37 Cr | 0.30 Cr |
| Total Other Finance Cost | — | — | — | 0.43 Cr | 0.42 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on ACUTAAS CHEMICALS LIMITED
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.